Protalix Biotherapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Protalix Biotherapeutics, Inc. on October 28, 2008. The filing serves as a Regulation FD disclosure regarding upcoming management presentations at industry conferences.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces scheduled corporate events.
Guidance, Outlook, and Management Commentary
Dr. David Aviezer, President and Chief Executive Officer, is scheduled to present at the following events:
- 19th Annual Oppenheimer Healthcare Conference on November 3, 2008, at 4:00 PM EDT.
- Barclays Capital Small & Mid-Cap Healthcare Conference on November 6, 2008, at 9:30 AM EDT.
Audio webcasts of these presentations will be available on the Company's website under the events calendar section.
Key Facts for Investor Verification
- Verify the date and time of the upcoming conference presentations.
- Check the Company website (www.protalix.com) for access to the audio webcasts.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.